DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients

Dolutegravir (DTG) has shown effectiveness in combination with rilpivirine in with experience of antiretroviral therapy (ART) and with 3TC in naïve patients (GEMINI trial). The main objectives of this real-life study were to analyze the effectiveness and safety of 3TC plus DTG in virologically suppr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidalgo-Tenorio, Carmen, Cortés, Luis López, Gutiérrez, Alicia, Santos, Jesús, Omar, Mohamed, Gálvez, Carmen, Sequera, Sergio, Jesús, Samantha Eisabeth De, Téllez, Franciso, Fernández, Elisa, García, Coral, Pasquau, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708975/
https://www.ncbi.nlm.nih.gov/pubmed/31393412
http://dx.doi.org/10.1097/MD.0000000000016813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708975/
https://www.ncbi.nlm.nih.gov/pubmed/31393412
http://dx.doi.org/10.1097/MD.0000000000016813

Ejemplares similares